IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:1667-1673.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-1093

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aijaz, S.
Right arrow Articles by Votruba, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aijaz, S.
Right arrow Articles by Votruba, M.

Developmental Expression Profile of the Optic Atrophy Gene Product: OPA1 Is Not Localized Exclusively in the Mammalian Retinal Ganglion Cell Layer

Saima Aijaz,1 Lynda Erskine,1,2 Glen Jeffery,2 Shomi S. Bhattacharya,1 and Marcela Votruba1,3

1From the Departments of Molecular Genetics and 2Visual Science, Institute of Ophthalmology, London, United Kingdom; and 3Moorfields Eye Hospital, London, United Kingdom.

PURPOSE. Autosomal dominant optic atrophy (ADOA) is characterized by primary degeneration of retinal ganglion cells and atrophy of the optic nerve. The OPA1 gene encodes a 960-amino-acid protein. In the current study the temporal and spatial localization of OPA1 were examined in developing and adult murine ocular tissues and the adult human eye. Because the Bst/+ mouse has been postulated as a model of ADOA, the mOPA1 expression in the Bst/+ retina was also examined.

METHODS. A polyclonal antibody generated against a C-terminal peptide of OPA1 was used to assess by immunohistochemistry the expression of mOPA1 in the wild-type embryonic and postnatal mouse ocular tissues and the Bst/+ retina. Western blot analyses of total proteins from a panel of adult human tissues were used to examine the expression of human OPA1, and spatial localization was assessed by immunohistochemistry.

RESULTS. The ocular expression of mOPA1 begins at E15 in the inner retina in a location corresponding to that of the subsequently developing ganglion cell layer (GCL) and peaks between postnatal day (P)0 and P1 in the retina and the optic nerve. There is a sharp decline in mOPA1 expression after P2, but it is expressed at a basal level until at least P12 in the GCL, inner plexiform layer (IPL), and inner nuclear layer (INL) of the retina as well as in the optic nerve. In the adult Bst/+ retina, mOPA1 is strongly expressed in the GCL and IPL and weakly in the INL. In the adult human eye, OPA1 is expressed in the GCL, IPL, INL, and outer plexiform layer (OPL) of the retina and in the optic nerve, where it is observed only in the myelinated region.

CONCLUSIONS. OPA1 is not restricted to the GCL of the mammalian retina, and its expression extends into the IPL, INL, and OPL. OPA1 is distinctly expressed in the myelinated region beyond the lamina cribrosa in the human optic nerve, whereas its expression is weaker in the mouse optic nerve. In the Bst/+ mouse retina, despite the structural defects, mOPA1 expression is comparable to that observed in the wild-type adult mouse retina. These observations suggest a wider role for OPA1 than previously anticipated.





This article has been cited by other articles:


Home page
Hum Mol GenetHome page
V. J. Davies, A. J. Hollins, M. J. Piechota, W. Yip, J. R. Davies, K. E. White, P. P. Nicols, M. E. Boulton, and M. Votruba
Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function
Hum. Mol. Genet., June 1, 2007; 16(11): 1307 - 1318.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Miyata, M. Nakamura, M. Kondo, J. Lin, S. Ueno, Y. Miyake, and H. Terasaki
Reduction of Oscillatory Potentials and Photopic Negative Response in Patients with Autosomal Dominant Optic Atrophy with OPA1 Mutations
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 820 - 824.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Kamei, M. Chen-Kuo-Chang, C. Cazevieille, G. Lenaers, A. Olichon, P. Belenguer, G. Roussignol, N. Renard, M. Eybalin, A. Michelin, et al.
Expression of the Opa1 Mitochondrial Protein in Retinal Ganglion Cells: Its Downregulation Causes Aggregation of the Mitochondrial Network
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4288 - 4294.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
U. E. A. Pesch, J. E. Fries, S. Bette, H. Kalbacher, B. Wissinger, C. Alexander, and K. Kohler
OPA1, the Disease Gene for Autosomal Dominant Optic Atrophy, Is Specifically Expressed in Ganglion Cells and Intrinsic Neurons of the Retina
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4217 - 4225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology